Global Sacral Nerve Stimulation Market will grow at highest pace owing to rising procedural volume

Sacral nerve stimulation involves delivering mild electrical pulses to the sacral nerve located in the lower back or buttocks to treat urinary and fecal incontinence as well as constipation. It offers an alternative to surgical interventions and drug therapies by neuromodulating the areas of the brain and spinal cord that control bladder and bowel function. Sacral nerve stimulation devices consist of a small pulse generator that is implanted underneath the skin near the buttocks which delivers electrical impulses to the sacral nerve. Need for minimally invasive and effective treatment options for incontinence and constipation issues is driving the adoption of sacral nerve stimulation.

The Global Sacral Nerve Stimulation Market is estimated to be valued at US$ 422.7 Mn in 2024 and is expected to exhibit a CAGR of 6.0% over the forecast period 2024 To 2031.

Key Takeaways
Key players operating in the Global Sacral Nerve Stimulation Market Growth are Medtronic plc., Boston Scientific Corporation, Nevro Corp, StimWave Technologies Inc., Axonics, Inc., Synapse Biomedical, Uroplasty, St. Jude Medical, Cogentix Medical. Rising prevalence of urinary incontinence and fecal incontinence issues globally is fueling the demand for sacral nerve stimulation devices. According to the National Association for Incontinence, it is estimated that ~25 million people in the US suffer from some form of urinary incontinence alone. Technological advancements including miniaturization and improved battery lives of implantable pulse generators are expanding the potential patient pool for sacral nerve stimulation treatment.

Market Trends
The Global Sacral Nerve Stimulation Market is witnessing increasing adoption of rechargeable implantable pulse generators which offer improved functionality and longer battery lives. Manufacturers are also developing minimally invasive surgical techniques to facilitate device implantation with reduced procedure time and trauma. Wireless technology enabled sacral nerve stimulators allowing remote programming via smartphones are also gaining traction.

Market Opportunities
Untapped developing regions especially Asia Pacific and Latin America having high prevalence of incontinence issues present significant growth opportunities. Favorable reimbursement coverage and regulatory approvals help in penetrating these emerging markets. Additionally, potential expansion of sacral nerve stimulation into new therapeutic areas such as fecal incontinence and constipation syndrome present lucrative opportunities over the forecast period.

Impact of COVID-19 on Global Sacral Nerve Stimulation Market

The COVID-19 pandemic has significantly impacted the global sacral nerve stimulation market. With lockdowns imposed worldwide, the market witnessed a decline in 2020. Surgeries were postponed owing to depleted healthcare resources and risks of virus transmission. However, urgency of cases reduced waiting periods and hospitals turned their focus to critical patients. As markets recover in 2021, some challenges remain. Supply chain disruptions hampered device supplies to an extent. Staff shortages persist due to pandemic pressures as well as employees contracting the virus.

The market is projected to recover steadily through 2021-2024 as healthcare resources normalize. Increased priority for treating chronic pain and urological conditions is boosting the market again. Telehealth solutions helped continue consultations and remote monitoring during lockdowns. This also expanded the patient pool by improving accessibility. Device manufacturers are focusing on minimizing disruptions by diversifying suppliers and building flexibility in production. Companies are developing effective protocols at clinics to minimize infection risks while prioritizing urgent surgeries. The long term outlook remains positive supported by aging demographics, technological advancements and expanding applications.

Globally, the market in United States holds the major share in terms of value, aided by advanced healthcare infrastructure and availability of skilled professionals. North America has remained at the forefront with substantial research investments and continuous innovations. Europe is the second largest market driven by supportive reimbursement policies and focus on reducing opioid dependence for pain management. Asia Pacific is expected to emerge as the fastest growing regional market owing to rising medical expenditures, increasing patient awareness and improving access in major countries like China and India.

Globally, high unmet needs, existence of untapped rural markets and rising healthcare expenditures present significant opportunities for continued market growth in the long run. However, success would require navigating challenges of resource constraints, investments in training and technology adoption in emerging regions. Continued collaboration between industry and healthcare providers holds the key.